The U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee will hold a hearing on April 16 to discuss ways Congress can lower prescription drug costs for American families by encouraging greater competition among generic and biosimilar manufacturers. Senator Bill Cassidy, M.D., Chairman of the HELP Committee, is leading this initiative as part of an effort to make health care more affordable.
The upcoming hearing, titled “Making Medicines More Affordable: How Competition Can Lower Drug Prices,” is scheduled for Thursday at 10:00 AM Eastern Time in the Dirksen Senate Office Building. The committee invites members of the press to RSVP if they plan to attend in person.
The issue of rising prescription drug prices has been a significant concern for many Americans. The HELP Committee works to legislate on public health, education, workforce issues and retirement programs with the goal of protecting health and supporting worker rights, according to the official website. As chair during the 119th Congress, Cassidy leads oversight efforts that influence federal regulations affecting health and education across the United States according to the official website.
The committee also provides oversight of federal laws and agencies in both health and labor sectors. It serves as a key body for policy decisions that affect millions nationwide according to its official website. Its responsibilities include overseeing agencies such as the Food and Drug Administration (FDA) and National Institutes of Health (NIH), which play crucial roles in regulating medicines as described by its official site.
For further news or updates from HELP Republicans about this hearing or related initiatives, interested parties are encouraged to visit their website or follow them on Twitter at @GOPHELP.
